These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16011681)
1. Variance estimation in clinical studies with interim sample size re-estimation. Miller F Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681 [TBL] [Abstract][Full Text] [Related]
2. Methods of estimation in log odds ratio regression models. Breslow NE; Cologne J Biometrics; 1986 Dec; 42(4):949-54. PubMed ID: 3814734 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Lachin JM; Foulkes MA Biometrics; 1986 Sep; 42(3):507-19. PubMed ID: 3567285 [TBL] [Abstract][Full Text] [Related]
4. General statistical design considerations of randomized clinical trials. Peduzzi P Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035 [TBL] [Abstract][Full Text] [Related]
5. A Bayesian analysis of the two-period crossover design for clinical trials. Grieve AP Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262 [TBL] [Abstract][Full Text] [Related]
7. Designs for slope ratio assays. Buonaccorsi JP Biometrics; 1986 Dec; 42(4):875-82. PubMed ID: 3814728 [TBL] [Abstract][Full Text] [Related]
8. Changing frequency of interim analysis in sequential monitoring. Lan KK; DeMets DL Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114 [TBL] [Abstract][Full Text] [Related]
9. Nonparametric estimation of duration of accrual and total study length for clinical trials. Morgan TM Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175 [TBL] [Abstract][Full Text] [Related]
10. Investigating maximum power losses in survival studies with nonstratified randomization. Palta M Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324 [TBL] [Abstract][Full Text] [Related]
11. Alternative estimation procedures for Pr(X less than Y) in categorized data. Simonoff JS; Hochberg Y; Reiser B Biometrics; 1986 Dec; 42(4):895-907. PubMed ID: 3814730 [TBL] [Abstract][Full Text] [Related]
12. How do we know what we know? The randomized controlled trial revisited. Heaney RP J Bone Miner Res; 1991 Feb; 6(2):103-5. PubMed ID: 2028831 [No Abstract] [Full Text] [Related]
14. The B-value: a tool for monitoring data. Lan KK; Wittes J Biometrics; 1988 Jun; 44(2):579-85. PubMed ID: 3390511 [TBL] [Abstract][Full Text] [Related]
15. Tests of significance using regression models for ordered categorical data. Snapinn SM; Small RD Biometrics; 1986 Sep; 42(3):583-92. PubMed ID: 3567291 [TBL] [Abstract][Full Text] [Related]
16. Robust estimation of the variance in moment methods for extra-binomial and extra-Poisson variation. Moore DF; Tsiatis A Biometrics; 1991 Jun; 47(2):383-401. PubMed ID: 1912253 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of psychotropic drugs: implications for power analysis. Davis JM; Janicak PG; Wang Z; Gibbons RD; Sharma RP Psychopharmacol Bull; 1992; 28(2):151-5. PubMed ID: 1513917 [TBL] [Abstract][Full Text] [Related]
18. Analysis of two-period crossover design in a multicenter clinical trial. Castellana JV; Patel HI Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261 [TBL] [Abstract][Full Text] [Related]
19. More on "Biased selection of controls for case-control analyses of cohort studies". Robins JM; Gail MH; Lubin JH Biometrics; 1986 Jun; 42(2):293-9. PubMed ID: 3741971 [TBL] [Abstract][Full Text] [Related]
20. Use of baseline data for estimation of treatment effects in the presence of regression to the mean. Chen S; Cox C Biometrics; 1992 Jun; 48(2):593-8. PubMed ID: 1637982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]